5585

    543350

    VIJAYA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VIJAYA DIAGNOSTIC CEN LTD Share Price Today

    VIJAYA DIAGNOSTIC CEN LTD is currently trading at ₹1347.4, down by ₹17.79 from the previous close. The stock touched an intraday high of ₹1385.30 and a low of ₹1321.60 during the latest trading session. Over the past one year, VIJAYA DIAGNOSTIC CEN LTD has delivered a return of 36.09%, while the stock has gained 6.7% in the last one month.

    VIJAYA DIAGNOSTIC CEN LTD performance

    Today’s low Today’s high
    ₹ 1321.60 ₹ 1385.30
    ₹ 1339.20
    52 week low 52 week high
    ₹ 848.00 ₹ 1427.80
    ₹ 1339.20
    Open Price ₹ 1365.20
    Prev. Close ₹ 1365.20
    Volume (Shares) 216970.00
    Total traded value ₹ 2905.66
    Upper Circuit ₹ 1638.20
    Lower Circuit ₹ 1092.20
    info

    Investment Returns

    Over 1 Month 6.70% Over 3 Months 51.92% Over 6 Months 29.29% Over 1 Year 36.09%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VIJAYA DIAGNOSTIC CEN LTD fundamentals


    • Market cap (Cr) 13,759.40
    • P/E Ratio (TTM) 78.75
    • Beta 0.43
    • Book Value / share 91.68
    • Return on equity 18.79%
    • EPS (TTM) 17.33
    • Dividend yield 0.15%
    • Net profit/quarter (Cr) 52.65
    info icon alternate text
    • Market cap (Cr) 13,870.50
    • P/E Ratio (TTM) 78.75
    • Beta 0.30
    • Book Value / share 91.68
    • Return on equity 18.79%
    • EPS (TTM) 17.33
    • Dividend yield 0.15%
    • Net profit/quarter (Cr) 52.65
    info icon alternate text

    VIJAYA DIAGNOSTIC CEN LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 206.27
    Operating Expense 145.23
    Net Profit 52.65
    Net Profit Margin (%) 25.52
    Earnings Per Share (EPS) 5.12
    EBITDA 98.42
    Effective Tax Rate (%) 22.86
    Particulars DEC 2025 (Values in Cr)
    Revenue 193.08
    Operating Expense 139.60
    Net Profit 44.21
    Net Profit Margin (%) 22.89
    Earnings Per Share (EPS) 4.30
    EBITDA 88.23
    Effective Tax Rate (%) 25.10
    Particulars SEP 2025 (Values in Cr)
    Revenue 189.35
    Operating Expense 137.45
    Net Profit 42.70
    Net Profit Margin (%) 22.55
    Earnings Per Share (EPS) 4.15
    EBITDA 83.66
    Effective Tax Rate (%) 25.15
    Particulars JUN 2025 (Values in Cr)
    Revenue 176.73
    Operating Expense 131.91
    Net Profit 38.75
    Net Profit Margin (%) 21.92
    Earnings Per Share (EPS) 3.76
    EBITDA 77.32
    Effective Tax Rate (%) 25.55
    Particulars MAR 2025 (Values in Cr)
    Revenue 161.64
    Operating Expense 120.55
    Net Profit 33.42
    Net Profit Margin (%) 20.67
    Earnings Per Share (EPS) 3.23
    EBITDA 69.28
    Effective Tax Rate (%) 26.59
    Particulars MAR 2026 (Values in Cr)
    Revenue 765.43
    Operating Expense 554.20
    Net Profit 178.31
    Net Profit Margin (%) 23.29
    Earnings Per Share (EPS) 17.33
    EBITDA 347.64
    Effective Tax Rate (%) 24.56
    Particulars MAR 2025 (Values in Cr)
    Revenue 634.00
    Operating Expense 468.97
    Net Profit 135.93
    Net Profit Margin (%) 21.44
    Earnings Per Share (EPS) 13.23
    EBITDA 272.17
    Effective Tax Rate (%) 25.52
    Particulars MAR 2024 (Values in Cr)
    Revenue 525.02
    Operating Expense 391.94
    Net Profit 114.60
    Net Profit Margin (%) 21.82
    Earnings Per Share (EPS) 11.21
    EBITDA 231.59
    Effective Tax Rate (%) 24.83
    Particulars MAR 2023 (Values in Cr)
    Revenue 449.58
    Operating Expense 352.88
    Net Profit 83.23
    Net Profit Margin (%) 18.51
    Earnings Per Share (EPS) 8.16
    EBITDA 193.54
    Effective Tax Rate (%) 25.19
    Particulars MAR 2022 (Values in Cr)
    Revenue 450.88
    Operating Expense 319.42
    Net Profit 108.10
    Net Profit Margin (%) 23.97
    Earnings Per Share (EPS) 10.60
    EBITDA 212.77
    Effective Tax Rate (%) 25.12
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 77.53
    ROE % 19.79
    ROCE % 21.42
    Total Debt to Total Equity 0.40
    EBITDA Margin 41.26
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 64.21
    ROE % 19.91
    ROCE % 21.15
    Total Debt to Total Equity 0.42
    EBITDA Margin 43.75
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 53.37
    ROE % 16.82
    ROCE % 18.43
    Total Debt to Total Equity 0.43
    EBITDA Margin 42.72
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 45.92
    ROE % 26.76
    ROCE % 28.07
    Total Debt to Total Equity 0.39
    EBITDA Margin 46.83
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 79.22
    ROE % 26.87
    ROCE % 26.77
    Total Debt to Total Equity 0.48
    EBITDA Margin 47.20
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 76.34
    ROE % 18.79
    ROCE % 20.64
    Total Debt to Total Equity 0.38
    EBITDA Margin 41.67
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 63.83
    ROE % 17.17
    ROCE % 18.75
    Total Debt to Total Equity 0.42
    EBITDA Margin 39.79
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 53.40
    ROE % 16.40
    ROCE % 18.10
    Total Debt to Total Equity 0.42
    EBITDA Margin 43.05
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 46.09
    ROE % 26.03
    ROCE % 27.59
    Total Debt to Total Equity 0.38
    EBITDA Margin 47.19
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 79.56
    ROE % 25.96
    ROCE % 26.32
    Total Debt to Total Equity 0.46
    EBITDA Margin 47.41
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 48.87
    Total Assets 1273.61
    Total Liabilities 1273.61
    Total Equity 799.14
    Share Outstanding 10
    Price to Book Ratio 13.19
    Return on Assets (%) 11.23
    Return on Capital (%) 17.9
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 73.07
    Total Assets 982.75
    Total Liabilities 982.75
    Total Equity 659.91
    Share Outstanding 10
    Price to Book Ratio 9.95
    Return on Assets (%) 12.09
    Return on Capital (%) 18.01
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 116.42
    Total Assets 853.40
    Total Liabilities 853.40
    Total Equity 546.63
    Share Outstanding 10
    Price to Book Ratio 7.33
    Return on Assets (%) 9.91
    Return on Capital (%) 15.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 192.35
    Total Assets 713.46
    Total Liabilities 713.46
    Total Equity 469.54
    Share Outstanding 10
    Price to Book Ratio 9.50
    Return on Assets (%) 15.37
    Return on Capital (%) 23.33
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 194.24
    Total Assets 541.24
    Total Liabilities 541.24
    Total Equity 359.23
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) 15.60
    Return on Capital (%) 23.23
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 41.19
    Total Assets 1223.93
    Total Liabilities 1223.93
    Total Equity 783.52
    Share Outstanding 10
    Price to Book Ratio 13.19
    Return on Assets (%) 11.03
    Return on Capital (%) 17.23
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 62.01
    Total Assets 962.13
    Total Liabilities 962.13
    Total Equity 653.32
    Share Outstanding 10
    Price to Book Ratio 9.95
    Return on Assets (%) 11.91
    Return on Capital (%) 17.54
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 111.42
    Total Assets 850.06
    Total Liabilities 850.06
    Total Equity 545.08
    Share Outstanding 10
    Price to Book Ratio 7.33
    Return on Assets (%) 9.79
    Return on Capital (%) 15.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 186.05
    Total Assets 710.83
    Total Liabilities 710.83
    Total Equity 469.98
    Share Outstanding 10
    Price to Book Ratio 9.50
    Return on Assets (%) 15.20
    Return on Capital (%) 23
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 188.54
    Total Assets 533.15
    Total Liabilities 533.15
    Total Equity 360.54
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) 15.53
    Return on Capital (%) 22.97
    Particulars MAR 2025 (Values in Cr)
    Net Income 193.16
    Cash from Operations 264.38
    Cash from Investing -181.87
    Cash from Financing -52.04
    Net change in Cash -9.44
    Free Cash Flow 359.94
    Particulars MAR 2024 (Values in Cr)
    Net Income 158.68
    Cash from Operations 217.20
    Cash from Investing -142.30
    Cash from Financing -44.54
    Net change in Cash -3.55
    Free Cash Flow 305.16
    Particulars MAR 2023 (Values in Cr)
    Net Income 113.51
    Cash from Operations 190.83
    Cash from Investing -109.57
    Cash from Financing -41.91
    Net change in Cash 13.12
    Free Cash Flow 315.67
    Particulars MAR 2022 (Values in Cr)
    Net Income 147.38
    Cash from Operations 197.92
    Cash from Investing -123.06
    Cash from Financing -30.57
    Net change in Cash 4.36
    Free Cash Flow 320.27
    Particulars MAR 2021 (Values in Cr)
    Net Income 112.12
    Cash from Operations 160.86
    Cash from Investing -129.74
    Cash from Financing -48.76
    Net change in Cash -48.88
    Free Cash Flow 192.99
    Particulars MAR 2025 (Values in Cr)
    Net Income 181.30
    Cash from Operations 243.79
    Cash from Investing -165.36
    Cash from Financing -46.83
    Net change in Cash -5.59
    Free Cash Flow 316.81
    Particulars MAR 2024 (Values in Cr)
    Net Income 152.47
    Cash from Operations 208.23
    Cash from Investing -139.14
    Cash from Financing -43.34
    Net change in Cash -7.72
    Free Cash Flow 294.15
    Particulars MAR 2023 (Values in Cr)
    Net Income 111.27
    Cash from Operations 188.71
    Cash from Investing -108.47
    Cash from Financing -41.25
    Net change in Cash 12.89
    Free Cash Flow 313.16
    Particulars MAR 2022 (Values in Cr)
    Net Income 144.38
    Cash from Operations 194.59
    Cash from Investing -126.62
    Cash from Financing -24.71
    Net change in Cash 4.07
    Free Cash Flow 316.69
    Particulars MAR 2021 (Values in Cr)
    Net Income 109.58
    Cash from Operations 159.00
    Cash from Investing -128.82
    Cash from Financing -48.18
    Net change in Cash -49.17
    Free Cash Flow 190.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 65.40 13.50 127930.24 6680.00 8917.95
    FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 76.00
    SHREE PACETRONIX LTD. 129.50 15.45 2.72 48.56 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 85.22 12.84 127930.24 6680.00 8917.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.43 0.00 -9.35 28.71 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6041.50 27.04 5.00 6609.40 5010.00 6725.00

    VIJAYA DIAGNOSTIC CEN LTD shareholding pattern

    Holding
    4.17%
    52.51%
    13.37%
    29.93%
    1.48%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    VIJAYA DIAGNOSTIC CEN LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1337.20 -2.05 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 1363.60
    • 26 Days 1312.10
    • 10 Days 1348.30
    • 50 Days 1253.80
    • 12 Days 1343.40
    • 100 Days 1170.60
    • 20 Days 1325.70
    • 200 Days 1101.00
    1377.90 PIVOT
    First Support 1347.80 First Resistance 1395.30 Second Support 1330.40 Second Resistance 1425.40 Third Support 1300.30 Third Resistance 1442.80
    RSI 56.98 ADX 34.30 MACD 31.29 Williams % R -34.30 Commodity Channel Index (CCI) 114.22
    Date 2026-07-03 Week 305043.00 Same Day 58952.00 Month 158538.00
    1 Year 0.43 3 Year 0.46
    Over 1 Month
    6.70% down
    Over 1 Year
    36.09% down
    Over 3 Months
    51.92% down
    Over 3 Years
    41.87% down
    Over 6 Months
    29.29% down
    Over 5 Years
    17.09% down

    VIJAYA DIAGNOSTIC CEN LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    29 Aug 2025 2.0 Final 29 Aug 2025 Equity shares
    30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
    13 Sep 2023 1.0 Final 13 Sep 2023 Equity shares
    20 Sep 2022 1.0 Final 21 Sep 2022 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    29 Aug 2025 2.0 Final 29 Aug 2025 Equity shares
    30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
    13 Sep 2023 1.0 Final 13 Sep 2023 Equity shares
    20 Sep 2022 1.0 Final 21 Sep 2022 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vijaya Diagnostic Centre Ltd?

    Answer Field

    Vijaya Diagnostic Centre Ltd share price is for NSE ₹ 1,347.40 & for BSE ₹ 1,347.55 as on Jul 06 2026 03:30 PM.

    What is the Market Cap of Vijaya Diagnostic Centre Ltd Share?

    Answer Field

    The market cap of Vijaya Diagnostic Centre Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 06 2026 03:30 PM.

    What is the 52 Week High and Low of Vijaya Diagnostic Centre Ltd?

    Answer Field

    The 52 Week High and Low of Vijaya Diagnostic Centre Ltd for NSE is ₹ 1,427.80 and ₹ 848.00 and for BSE is ₹ 1,425.00 and ₹ 847.90.

    What is 1 year return for Vijaya Diagnostic Centre Ltd?

    Answer Field

    The 1 year returns on the stock has been 36.09%.

    What is the P/E Ratio of Vijaya Diagnostic Centre Ltd Share?

    Answer Field

    As on Jul 06 2026 03:30 PM the price-to-earnings (PE) ratio for Vijaya Diagnostic Centre Ltd share is 78.75.

    What is the PB ratio of Vijaya Diagnostic Centre Ltd Share?

    Answer Field

    As on Jul 06 2026 03:30 PM, the price-to-book (PB) ratio for Vijaya Diagnostic Centre Ltd share is 91.68.

    How to Buy Vijaya Diagnostic Centre Ltd Share?

    Answer Field

    You can trade in Vijaya Diagnostic Centre Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vijaya Diagnostic Centre Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vijaya Diagnostic Centre Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Vijaya Diagnostic Centre Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |